Free Trial

X3 (XTKG) Competitors

$1.40 +0.04 (+2.57%)
As of 11:35 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

XTKG vs. CDLX, RMBL, ICLK, DUOT, GAN, ASST, CCLD, UPLD, ZENV, and CNGL

Should you be buying X3 stock or one of its competitors? The main competitors of X3 include Cardlytics (CDLX), RumbleOn (RMBL), iClick Interactive Asia Group (ICLK), Duos Technologies Group (DUOT), GAN (GAN), Asset Entities (ASST), CareCloud (CCLD), Upland Software (UPLD), Zenvia (ZENV), and Canna-Global Acquisition (CNGL). These companies are all part of the "computer software" industry.

X3 vs.

Cardlytics (NASDAQ:CDLX) and X3 (NASDAQ:XTKG) are both small-cap business services companies, but which is the superior business? We will contrast the two companies based on the strength of their profitability, institutional ownership, dividends, valuation, media sentiment, analyst recommendations, community ranking, earnings and risk.

Cardlytics presently has a consensus price target of $5.20, indicating a potential upside of 170.13%. Given Cardlytics' stronger consensus rating and higher possible upside, equities analysts clearly believe Cardlytics is more favorable than X3.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Cardlytics
1 Sell rating(s)
5 Hold rating(s)
0 Buy rating(s)
1 Strong Buy rating(s)
2.14
X3
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

In the previous week, Cardlytics had 3 more articles in the media than X3. MarketBeat recorded 3 mentions for Cardlytics and 0 mentions for X3. Cardlytics' average media sentiment score of 1.48 beat X3's score of 0.00 indicating that Cardlytics is being referred to more favorably in the media.

Company Overall Sentiment
Cardlytics Positive
X3 Neutral

Cardlytics received 225 more outperform votes than X3 when rated by MarketBeat users.

CompanyUnderperformOutperform
CardlyticsOutperform Votes
225
56.68%
Underperform Votes
172
43.32%
X3N/AN/A

68.1% of Cardlytics shares are held by institutional investors. Comparatively, 1.9% of X3 shares are held by institutional investors. 4.4% of Cardlytics shares are held by company insiders. Comparatively, 23.9% of X3 shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

X3 has a net margin of 0.00% compared to Cardlytics' net margin of -93.55%. X3's return on equity of 0.00% beat Cardlytics' return on equity.

Company Net Margins Return on Equity Return on Assets
Cardlytics-93.55% -110.67% -32.70%
X3 N/A N/A N/A

X3 has lower revenue, but higher earnings than Cardlytics.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cardlytics$272.59M0.37-$134.70M-$3.56-0.54
X3$11.61M1.65-$109.60MN/AN/A

Cardlytics has a beta of 1.3, suggesting that its share price is 30% more volatile than the S&P 500. Comparatively, X3 has a beta of 1.41, suggesting that its share price is 41% more volatile than the S&P 500.

Summary

Cardlytics beats X3 on 8 of the 15 factors compared between the two stocks.

Get X3 News Delivered to You Automatically

Sign up to receive the latest news and ratings for XTKG and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

XTKG vs. The Competition

MetricX3Custom computer programming services IndustryBusiness SectorNASDAQ Exchange
Market Cap$19.11M$7.47B$24.45B$8.42B
Dividend YieldN/A2.95%2.48%4.10%
P/E RatioN/A100.1533.9919.69
Price / Sales1.6514.08269.37118.34
Price / CashN/A23.7730.9334.62
Price / Book0.135.125.404.50
Net Income-$109.60M$204.55M$196.34M$248.32M
7 Day Performance0.36%-1.39%-0.53%-0.03%
1 Month Performance38.39%6.66%15.40%12.72%
1 Year Performance-90.45%43.73%17.88%7.38%

X3 Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
XTKG
X3
0.4388 of 5 stars
$1.40
+2.6%
N/A-90.6%$19.11M$11.61M0.00200
CDLX
Cardlytics
3.5509 of 5 stars
$2.10
-3.2%
$5.20
+147.6%
-79.4%$110.25M$278.30M-0.34500Positive News
RMBL
RumbleOn
2.1228 of 5 stars
$2.62
+2.3%
$4.50
+71.8%
-68.4%$99.01M$1.21B-0.312,020Positive News
ICLK
iClick Interactive Asia Group
N/A$9.43
+12.3%
N/A+648.4%$95.63M$130.44M0.001,190Gap Up
High Trading Volume
DUOT
Duos Technologies Group
2.5894 of 5 stars
$7.47
+4.9%
$11.50
+53.9%
+219.5%$87.06M$7.28M-5.2270News Coverage
Earnings Report
Analyst Revision
Gap Up
GAN
GAN
0.7625 of 5 stars
$1.86
-1.6%
N/A+45.5%$86.17M$135.00M-6.20680Analyst Downgrade
ASST
Asset Entities
1.1637 of 5 stars
$5.97
-14.8%
N/A+336.4%$86.05M$633,489.00-3.0811News Coverage
Earnings Report
Gap Up
CCLD
CareCloud
1.7965 of 5 stars
$1.98
-2.5%
$2.50
+26.3%
-31.0%$83.80M$112.51M-0.624,100
UPLD
Upland Software
2.2947 of 5 stars
$2.75
-3.2%
N/A-11.2%$78.33M$274.79M-0.611,010Analyst Downgrade
ZENV
Zenvia
1.2334 of 5 stars
$1.77
+3.5%
N/A-60.3%$74.14M$945.26M-7.701,080News Coverage
Earnings Report
Gap Down
CNGL
Canna-Global Acquisition
N/A$10.74
flat
N/AN/A$70.99MN/A0.002

Related Companies and Tools


This page (NASDAQ:XTKG) was last updated on 5/22/2025 by MarketBeat.com Staff
From Our Partners